Pasar al contenido principal

FLAVANOLES DE LA DIETA DE ALTO PESO MOLECULAR COMO ADYUVANTES CARDIOPROTECTORES EN LA DIABETES TIPO 2: DESDE SUS MECANISMOS MOLECULARES A SUS EFECTOS PRE-CLINICOS Y CLINICOS

RTI2018-095059-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 30
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cocoa diet modulates gut microbiota composition and improves intestinal health in Zucker diabetic rats

  • Álvarez-Cilleros, David
  • Ramos, Sonia
  • López-Oliva, Elvira
  • Escrivá, Fernando
  • Álvarez, Carmen
  • Fernández-Millán, Elisa
  • Martín, M. Ángeles
Cocoa supplementation improves glucose metabolism in Zucker diabetic fatty (ZDF) rats via multiple mechanisms. Furthermore, cocoa rich-diets modify the intestinal microbiota composition both in humans and rats in healthy conditions. Accordingly, we hypothesized that cocoa could interact with the gut microbiota (GM) in ZDF rats, contributing to their antidiabetic effects. Therefore, here we investigate the effect of cocoa intake on gut health and GM in ZDF diabetic rats. Male ZDF rats were fed with standard (ZDF-C) or 10% cocoa-rich diet (ZDF-Co) during 10 weeks. Zucker Lean animals (ZL) received the standard diet. Colon tissues were obtained to determine the barrier integrity and the inflammatory status of the intestine and faeces were analysed for microbial composition, short-chain fatty acids (SCFA) and lactate levels. We found that cocoa supplementation up-regulated the levels of the tight junction protein Zonula occludens-1 (ZO-1) and the mucin glycoprotein and reduced the expression of pro-inflammatory cytokines such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1) in the colon of ZDF diabetic animals. Additionally, cocoa modulated the microbial composition of the ZDF rats to values similar to those of the lean group. Importantly, cocoa treatment increased the relative abundance of acetate-producing bacteria such as Blautia and prevented the increase in the relative amount of lactate-producing bacteria (mainly Enterococcus and Lactobacillus genera) in ZDF diabetic animals. Accordingly, the total levels of SCFA (mainly acetate) increased significantly in the faeces of ZDF-Co diabetic rats. Finally, modified GM was closely associated with improved biochemical parameters related to glucose homeostasis and intestinal integrity and inflammation. These findings demonstrate for the first time that cocoa intake modifies intestinal bacteria composition towards a healthier microbial profile in diabetic animals and suggest that these changes could be associated with the improved glucose homeostasis and gut health induced by cocoa in ZDF diabetic rats., This work was supported by grants AGL2015–67087-R, BFU2016-77931-R and RTI2018-095059-B-I00 (MINECO/FEDER, UE) from the Spanish Ministry of Science and Innovation (MINECO). D. Álvarez-Cilleros is a FPI fellow from the predoctoral program of MINECO (BES-2016-076721)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effect of Cocoa and Cocoa Products on Cognitive Performance in Young Adults

  • Martín, M. Ángeles
  • Goya, Luis
  • de Pascual-Teresa, Sonia
© 2020 by the authors., Increasing evidence support a beneficial role of cocoa and cocoa products on human cognition, particularly in aging populations and patients at risk. However, thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter. Thus, the aim of this study was to summarize the findings on the acute and chronic effects of cocoa administration on cognitive functions and brain health in young adults. Web of Science and PubMed databases were used to search for relevant trials. Human randomized controlled studies were selected according to PRISMA guidelines. Eleven intervention studies that involved a total of 366 participants investigating the role of cocoa on cognitive performance in children and young adults (average age ≤25 years old) were finally selected. Findings from individual studies confirm that acute and chronic cocoa intake have a positive effect on several cognitive outcomes. After acute consumption, these beneficial effects seem to be accompanied with an increase in cerebral blood flow or cerebral blood oxygenation. After chronic intake of cocoa flavanols in young adults, a better cognitive performance was found together with increased levels of neurotrophins. This systematic review further supports the beneficial effect of cocoa flavanols on cognitive function and neuroplasticity and indicates that such benefits are possible in early adulthood., This research was funded by Spanish Ministry of Science and Innovation (AEI/FEDER, UE), grant numbers AGL2016-76832-R and RTI2018-095059-B-I00.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling

  • Álvarez-Cilleros, David
  • López-Oliva, Elvira
  • Martín, M. Ángeles
  • Ramos, Sonia
Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role., This work was supported by the grants AGL2015-67087R and RTI2018-095059-B-I00 (MINECO/FEDER, UE) from the Spanish Ministry of Science and Innovation (MINECO). D. Álvarez-Cilleros is a FPI fellow from the predoctoral program of MINECO (BES-2016-076721)., We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Preventive effect of cocoa flavanols against glucotoxicity-induced vascular inflammation in the arteria of diabetic rats and on the inflammatory process in TNF-α-stimulated endothelial cells

  • Álvarez-Cilleros, David
  • López-Oliva, Elvira
  • Ramos, Sonia
  • Martín, M. Ángeles
Hyperglycaemia induces a vascular inflammatory process that is a critical event in cardiovascular disease in type 2 diabetes. Cocoa and its flavanols have been widely investigated for its antioxidant and anti-inflammatory properties, and several clinical and pre-clinical studies support their vascular benefits. However, the effects of cocoa flavanols on vascular inflammation in diabetes remains to be elucidated. Herein, we evaluated the anti-inflammatory effect of a cocoa-rich diet on the aortas of Zucker diabetic fatty (ZDF) rats. Moreover, the potential role of flavanol-derived colonic metabolites to modulate the adhesion and inflammatory processes were also evaluated using TNF-α-stimulated endothelial cells. Results demonstrate that cocoa attenuates the levels of phospho-p65-nuclear factor-kappaB (NF-κB) and the expression of inflammatory factors including intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1) and inducible nitric oxide synthase in the aortas of ZDF rats. Experiments with endothelial cells further confirm that a mix of flavanol-derived colonic metabolites effectively down-regulate the levels of p-p65-NF-κB and the cell adhesion molecules ICAM-1 and VCAM-1, preventing thus the increase of monocyte-endothelial adhesion induced by TNF-α. These novel data provide the first evidence of the relevant role of cocoa and their flavanol-derived metabolites to avoid the development of endothelial inflammation and diabetic complications., This work was supported by the grant AGL2015-67087-R (MINECO/FEDER, UE) and RTI2018-095059-B-I00 (MCIU/AEI/FEDER, UE). D. Álvarez-Cilleros is a fellow of the FPI predoctoral program (MINECO, BES-2016-076721)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evaluation of the potential of total proanthocyanidin content in feces as an intake biomarker

  • Magdaleno-Tapia, Cristina
  • Quifer-Rada, Paola
  • Rodríguez-Rodríguez, Elena
  • Estévez Santiago, Rocío
  • Waterhouse, Andrew L.
  • Lamuela-Raventós, Rosa M.
  • Olmedilla-Alonso, Begoña
  • Pérez-Jiménez, Jara
Due to the health benefits associated with proanthocyanidins (PAs), it is useful to identify dietary PA biomarkers that can be determined by simple methods. Since increased levels of circulating PA metabolites are associated with increased fecal PA content, this study explores the spectrophotometric measurement of fecal PA content and its use as a biomarker of PA intake. To this end, fecal PA content was measured using an adaptation of Porter’s spectrophotometric method in samples from a preclinical study and an observational study. In the former, excretion of 250–400 mg PA polymer equivalents/100 g feces was observed during supplementation and the day after, together with a significant association (p < 0.05) between PA intake and the excretion of both intact PAs and some PA metabolites, i.e., (+)-catechin, (−)-epicatechin and syringic acid. No relationship between intake and excretion was found in the observational study, either for the entire group (mean excretion of 240 ± 226 mg PA polymer equivalents/100 g feces) or after stratification into tertiles of consumption. In conclusion, the spectrophotometric determination of total PA content in feces proved to be a valid compliance marker in a preclinical study, but it was not associated with PA intake in free-living subjects. The potential of total PA excretion in observational studies, determined in fecal samples collected the day before dietary recall or in several fecal samples from the same subject, remains to be elucidated, as does a complete validation of the method proposed here., This study was funded...B-I00)" by this one: "This study was funded by grants PI16/01991 (Instituto de Salud Carlos III co-funded by the European Regional Development Fund/European Social Fund) and RTI2018-095059-B-I00 (Spanish Ministry of Science and Innovation/Spanish Research Agency, co-funded by the European Regional Development Fund)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dietary flavonoids and insulin signaling in diabetes and obesity

  • Martín, M. Ángeles
  • Ramos, Sonia
This article belongs to the Special Issue The Insulin Signaling Network in Health and Disease., Type 2 diabetes (T2D) and obesity are relevant worldwide chronic diseases. A common complication in both pathologies is the dysregulation of the insulin-signaling pathway that is crucial to maintain an accurate glucose homeostasis. Flavonoids are naturally occurring phenolic compounds abundant in fruits, vegetables and seeds. Rising evidence supports a role for the flavonoids against T2D and obesity, and at present, these compounds are considered as important potential chemopreventive agents. This review summarizes <i>in vitro</i> and <i>in vivo</i> studies providing data related to the effects of flavonoids and flavonoid-rich foods on the modulation of the insulin route during T2D and obesity. Notably, few human studies have evaluated the regulatory effect of these phenolic compounds at molecular level on the insulin pathway. In this context, it is also important to note that the mechanism of action for the flavonoids is not fully characterized and that a proper dosage to obtain a beneficial effect on health has not been defined yet. Further investigations will contribute to solve all these critical challenges and will enable the use of flavonoids to prevent, delay or support the treatment of T2D and obesity., This work was supported by the grant RTI2018-095059-B-I00 (MCIU/AEI/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Antioxidative stress actions of cocoa in colonic cancer: Revisited

  • Ramos, Sonia
  • Goya, Luis
  • Martín, M. Ángeles
Colorectal cancer is the third most common cancer in the world and is one of the major causes of cancer-related mortality in the world. Cancer is defined as a multistage process and divided into the following stages: initiation, promotion, and progression. In this disease, oxidative stress is involved in a large array of carcinogenic pathways associated with the proliferation of initiated cells and cellular malignancy. Therefore, the suppression of oxidative stress by natural antioxidant compounds has gained interest as an effective approach in colorectal cancer prevention. Accordingly, cocoa and its phenolic components have demonstrated to exert antioxidant activity and to be able to interfere with multiple carcinogenic signaling pathways. In this chapter, we reviewed the different in vitro and in vivo studies that have identified potential targets and mechanisms whereby cocoa and their flavonoid compounds could interfere with colonic cancer cells. In addition, recent evidence from human studies is also illustrated., This work was supported by the grants AGL2015-67087-R and RTI2018-095059-B-I00 (MINECO/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Labels on bars of solid chocolate and chocolate bar sweets in the Polish market: A nutritional approach and implications for the consumer

  • Hasan Yusuf, Emel
  • Pérez-Jiménez, Jara
The nutritional characteristics of chocolate products may be associated with very different, and even opposite, health effects. In the present study, we collected information on chocolate products on the Polish market to assess: (i) nutritional characteristics; (ii) ingredient order; (iii) the presence of nutritional claims on the label; (iv) packaging characteristics; and (v) any association between price and cocoa contents. A total of 220 bars of solid chocolate (90 % with at least 5 ingredients) and 147 chocolate bar sweets (90 % with at least 6 ingredients) were evaluated. Mean values for calorie, total lipid, saturated fatty acid, carbohydrate, protein, sugar and salt contents were significantly different between the bars of solid chocolate and chocolate bar sweets, although the values were widely dispersed in both categories. Some aspects of food labelling may result in confusion for the consumer (such as “vegan” claims). A weak (r = 0.459), although significant (p < 0.05), association was found between cocoa content and price (€/kg) in bars of solid chocolate, although no association was found in chocolate bar sweets. Thus, depending on chocolate product selection, nutritional benefits may be rather different: an aspect not evident to most consumers based on current chocolate bar labelling., This study was funded by the Spanish Ministry of Science and Innovation/Spanish Research Agency (RTI2018-095059-B-I00), co-funded by the European Regional Development Fund. E. H. Y. was granted a Talent Fellowship from the EIT Food RIS Fellowships project, 2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of diet on gut microbiota

  • Ramos, Sonia
  • Martín, M. Ángeles
In recent years, human gut microbiota (GM) has emerged as a potential target to modulate health and disease. GM could be shaped by different factors, being diet one of the major influences. It metabolizes ingested nutrients to produce an extensive range of microbial metabolites that may have an important impact on human physiology. In turn, dietary components modulate the composition and metabolic activity of the GM, causing either positive or negative effects on human health. However, nutrients are rarely consumed independently and research on diet–microbiota relationship has progressively moved from the study of individual dietary components toward overall dietary patterns. This review summarized recent advances on the influence of food components and dietary patterns on GM and their subjacent impact on human health., This work was supported by the grant RTI2018-095059-B-I00 from the Spanish Ministry of Science and Innovation (MCIU/AEI/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of cocoa flavanols on human health

  • Martín, M. Ángeles
  • Ramos, Sonia
Cocoa is a source of flavanols, and these phenolic compounds exert beneficial effects on health and aging, and reduce the risk of suffering chronic diseases (cardiovascular diseases, metabolic disorders, cancer). An increasing body of evidence has emerged to suggest that cocoa flavanols potentially are important chemopreventive natural agents. This review summarizes human studies from the past two decades, providing data related to the effects derived from cocoa intake on health and disease. Most human studies have reported beneficial effects of cocoa consumption on health and chronic diseases; however, outcomes are not unequivocal. Review of human studies enable to identify different mechanisms of action for cocoa, although they are not fully understood at present. In addition, it remains unclear whether cocoa consumption should be recommended to healthy subjects or to patients and what is the appropriate dosage or duration of cocoa consumption. Elucidation of information regarding these crucial issues could lead to cocoa use as an approach for decreasing the risk of certain chronic diseases, as well as improving health and quality of life., This work was supported by the RTI2018-095059-B-I00 (MCIU/AEI/FEDER, UE) grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Impact of dietary flavanols on microbiota, immunity and inflammation in metabolic diseases

  • Martín, M. Ángeles
  • Ramos, Sonia
This article belongs to the Special Issue Dietary Modulation of the Immune Function: Direct and Microbiota Dependent Effects., Flavanols are natural occurring polyphenols abundant in fruits and vegetables to which have been attributed to beneficial effects on health, and also against metabolic diseases, such as diabetes, obesity and metabolic syndrome. These positive properties have been associated to the modulation of different molecular pathways, and importantly, to the regulation of immunological reactions (pro-inflammatory cytokines, chemokines, adhesion molecules, nuclear factor-κB [NF-κB], inducible enzymes), and the activity of cells of the immune system. In addition, flavanols can modulate the composition and function of gut microbiome in a prebiotic-like manner, resulting in the positive regulation of metabolic pathways and immune responses, and reduction of low-grade chronic inflammation. Moreover, the biotransformation of flavanols by gut bacteria increases their bioavailability generating a number of metabolites with potential to affect human metabolism, including during metabolic diseases. However, the exact mechanisms by which flavanols act on the microbiota and immune system to influence health and disease remain unclear, especially in humans where these connections have been scarcely explored. This review seeks to summarize recent advances on the complex interaction of flavanols with gut microbiota, immunity and inflammation focus on metabolic diseases., This work was supported by the grant RTI2018-095059-B-I00 (MCIU/AEI/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Evaluación preliminar del efecto de los flavanoles en el metabolismo postprandial en sujetos con diabetes tipo 2, Preliminary evaluation of flavonol effects on postprandial metabolism in subjects with type 2 diabetes

  • García-Díez, Esther
  • Martín, M. Ángeles
  • Vicente-Díez, Ignacio
  • García-Cabrera, Sara
  • Ramos, Sonia
  • Pérez-Jiménez, Jara
Resumen del trabajo presentado al I Simposio de Jóvenes Investigadores de la Real Academia Nacional de Medicina, celebrado on-line los días 17 y 18 de noviembre de 2021., Agencia Estatal de Investigación (RTI2018-095059-B-I00), con cofinanciación de fondos FEDER (UE). Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid y Fondo Social Europeo (PEJ-2020-AI/BIO-18529)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Polifenoles de la dieta como potenciales coadyuvantes en patologías cardiometabólicas, Dietary polyphenols as potential coadjuvants in cardiometabolic pathologies

  • Pérez-Jiménez, Jara
Resumen del trabajo presentado al I Simposio de Jóvenes Investigadores de la Real Academia Nacional de Medicina, celebrado on-line los días 17 y 18 de noviembre de 2021., Agencia Estatal de Investigación (AGL2014-55102-JIN, RTI2018-095059-B-I00), con cofinanciación de fondos FEDER (UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring a cocoa–carob blend as a functional food with decreased bitterness: Characterization and sensory analysis

  • García-Díez, Esther
  • Sánchez-Ayora, Helena
  • Blanch Rojo, María
  • Ramos, Sonia
  • Martín, M. Ángeles
  • Pérez-Jiménez, Jara
Cumulative evidence indicates the relevance of cocoa in the modulation of cardiometabolic diseases. Nevertheless, pure cocoa may be rejected by many consumers due to its bitter taste. Carob (Ceratonia siliqua L.) is a Mediterranean legume with pods rich in dietary fibre and polyphenols. In this study, carob flour was combined with cocoa, to obtain a blend which was subjected to nutritional evaluation (proximate composition, carbohydrate and fatty acid profiles, phytochemical composition, dietary fibre properties, antioxidant capacity) and sensory analysis, in order to determine whether it may be a suitable alternative to commercial sugar-rich soluble cocoa powders. The blend showed a high content of dietary fibre (56%), methylxanthines and polyphenols (55% as non-extractable proanthocyanidins). The product had good solubility and was less bitter than cocoa, as evaluated in sensory analysis, thereby suggesting that this blend may be acceptable to consumers, particularly when information about potential biological activity is provided (a significant improvement in taste evaluation was observed). The beneficial environmental impact of carob and the advantages of valorizing the commonly discarded carob pod mean that further studies of applications of this blend and its potential health effects would be of great interest., This study was performed within the project RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/and by the European Regional Development Fund “Una manera de hacer Europa”. H.S.-A. was the recipient of a JAE-Intro fellowship from the CSIC (JAEINT_20_00536) and E.G.-D. of a contract from the European Youth Employment Initiative (Ref: CAM20_ICTAN_AI_01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic regulation of (−)-epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid on the glucose uptake, lipid accumulation and insulin signalling in cardiac H9c2 cells

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Pérez-Jiménez, Jara
  • Martín, M. Ángeles
  • Ramos, Sonia
Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake have been suggested to exert healthful effects, although their mechanism of action remains unknown. Heart damage is highly prevalent in metabolic diseases, and the failure of this organ is a major cause of death worldwide. In this study, the modulation of the energy metabolism and insulin signalling by the mentioned compounds in cardiac H9c2 cells was evaluated. Incubation of cells with EC (1–20 μM) and 2,3-dihydroxybenzoic acid (DHBA, 10 μM) reduced glucose uptake, and both compounds decreased lipid accumulation at concentrations higher than 0.5 μM. EC and DHBA also increased the tyrosine phosphorylated and total insulin receptor (IR) levels, and activated the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway in cardiac H9c2 cells. Interestingly, EC and DHBA did not modify glucose transporters (SGLT-1 and GLUT-1) levels, and increased GLUT-4 values. In addition, EC and DHBA decreased cluster of differentiation 36 (CD36) and fatty acid synthase (FAS) values, and enhanced carnitine palmitoyl transferase 1 (CPT1) and proliferator activated receptor α (PPARα) levels. By using specific inhibitors of AKT and 5′-AMP-activated protein kinase (AMPK), the participation of both proteins in EC- and DHBA-mediated regulation on glucose uptake and lipid accumulation was shown. Taken together, EC and DHBA modulate glucose uptake and lipid accumulation via AKT and AMPK, and reinforce the insulin signalling by activating key proteins of this pathway in H9c2 cells., This work was supported by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”. E. G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529). Sergio Castillo-González technical assistance is acknowledged (contracted by Comunidad de Madrid, PEJ-2018-TL/SAL-10236)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Supplementation with a cocoa–carob blend, alone or in combination with metformin, attenuates diabetic cardiomyopathy, cardiac oxidative stress and inflammation in Zucker diabetic rats

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Caro-Vadillo, Alicia
  • Pérez-Vizcaíno, Francisco
  • Pérez-Jiménez, Jara
  • Ramos, Sonia
  • Martín, M. Ángeles
This article belongs to the Special Issue Oxidative Stress in Metabolic Cardiomyopathy., Diabetic cardiomyopathy (DCM) is one of the main causes of mortality among diabetic patients, with oxidative stress and inflammation major contributors to its development. Dietary flavonoids show strong antioxidant and anti-inflammatory activities, although their potential additive outcomes in combination with antidiabetic drugs have been scarcely explored. The present study investigates the cardioprotective effects of a cocoa–carob blend (CCB) diet, rich in flavonoids, alone or in combination with metformin, in the development of DCM. Zucker diabetic fatty rats (ZDF) were fed with a CCB rich-diet or a control diet, with or without metformin for 12 weeks. Glucose homeostasis, cardiac structure and function, and oxidative and inflammatory biomarkers were analysed. CCB improved glucose homeostasis, and mitigated cardiac dysfunction, hypertrophy, and fibrosis in ZDF rats. Mechanistically, CCB counteracted oxidative stress in diabetic hearts by down-regulating NADPH oxidases, reducing reactive oxygen species (ROS) generation and modulating the sirtuin-1 (SIRT1)/ nuclear factor E2-related factor 2 (Nrf2) signalling pathway, overall improving antioxidant defence. Moreover, CCB suppressed inflammatory and fibrotic reactions by inhibiting nuclear factor kappa B (NFκB) and pro-inflammatory and pro-fibrotic cytokines. Noteworthy, several of these effects were further improved in combination with metformin. Our results demonstrate that CCB strongly prevents the cardiac remodelling and dysfunction observed in diabetic animals, highlighting its potential, alone or in adjuvant therapy, for treating DCM., This work was supported by the grant RTI2018-095059-B-I00 and PID2019-107363RB-I00, funded by MCIN/AEI/10.13039/501100011033/and by “ERDF A way of making Europe”. E.G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Urinary metabolomics study on the protective role of cocoa in Zucker diabetic rats via 1H-NMR-based approach

  • Fernández-Millán, Elisa
  • Ramos, Sonia
  • Álvarez-Cilleros, David
  • Samino, Sara
  • Amigó, Nuria
  • Correig, Xavier
  • Chagoyen, Mónica
  • Álvarez, Carmen
  • Martín, M. Ángeles
This article belongs to the Special Issue Effects of Polyphenol-Rich Foods on Chronic Diseases., Cocoa constitutes one of the richest sources of dietary flavonoids with demonstrated anti-diabetic potential. However, the metabolic impact of cocoa intake in a diabetic context remains unexplored. In this study, metabolomics tools have been used to investigate the potential metabolic changes induced by cocoa in type 2 diabetes (T2D). To this end, male Zucker diabetic fatty rats were fed on standard (ZDF) or 10% cocoa-rich diet (ZDF-C) from week 10 to 20 of life. Cocoa supplementation clearly decreased serum glucose levels, improved glucose metabolism and produced significant changes in the urine metabolome of ZDF animals. Fourteen differential urinary metabolites were identified, with eight of them significantly modified by cocoa. An analysis of pathways revealed that butanoate metabolism and the synthesis and degradation of branched-chain amino acids and ketone bodies are involved in the beneficial impact of cocoa on diabetes. Moreover, correlation analysis indicated major associations between some of these urine metabolites (mainly valine, leucine, and isoleucine) and body weight, glycemia, insulin sensitivity, and glycated hemoglobin levels. Overall, this untargeted metabolomics approach provides a clear metabolic fingerprint associated to chronic cocoa intake that can be used as a marker for the improvement of glucose homeostasis in a diabetic context., This work was supported by the grant RTI2018-095059-B-I00 and PID2020-116134RB-I00 and funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Does metformin affect polyphenol metabolic fate? A supplementation study with a cocoa-carob blend in Zucker diabetic rats

  • García-Díez, Esther
  • Dias de Melo, Gustavo
  • Martín, M. Ángeles
  • Ramos, Sonia
  • Pérez-Jiménez, Jara
Trabajo presentado al 15th World Congress on Polyphenols Applications, celebrado en Valencia (España) del 28 al 30 de septiembre de 2022., RTI2018-095059-B-100. ERDF A way of making europe. PEJ-2020-AI/BIO-18529., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

(-)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid strengthen insulin signalling and regulate glucose uptake and lipid accumulation in cardiomyocytes

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Pérez-Jiménez, Jara
  • Martín, M. Ángeles
  • Ramos, Sonia
Trabajo presentado al 15th World Congress on Polyphenols Applications, celebrado en Valencia (España) del 28 al 30 de septiembre de 2022., RTI2018-095059-B-100. ERDF A way of making europe. PEJ-2020-AI/BIO-18529., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Microbial metabolites of flavanols regulate glucose uptake, lipid accumulation and insulin signaling, and protect against glucolipotoxicity- induced damage in human cardiomyocytes

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Pérez-Jiménez, Jara
  • Martín, M. Ángeles
  • Ramos, Sonia
Resumen del trabajo presentado al 13th Annual Meeting CIBERDEM, celebrado en Mataró (Barcelona) del 9 al 11 de noviembre de 2022., Heart damage is highly prevalent in metabolic diseases, including diabetes, and the failure of this organ is a major cause of death worldwide. Risk of heart failure has been associated to a generalized insulin resistance, and disarrangements in the energy metabolism and oxidative stress of this organ. Accordingly, in the last years, the identification of natural compounds that may protect against the loss of functionality of cardiac cells has become a main topic. In this line, flavanols, the major antioxidants in cocoa, have demonstrated to lower the cardiovascular risk. However, their bioavailability is very low, and their bioactivity in vivo seems to be highly mediated by derived phenolic metabolites generated by the intestinal microbiota. The aim of this work was to investigate the in vitro effects of epicatechin (EC) and the microbial-derived flavanol metabolites 3,4-dihydroxyphenylacetic acid (DHPAA), 2,3- dihydroxybenzoic acid (DHBA) and 3-hydroxyphenylpropionic acid (HPPA) on the modulation of the energy metabolism and insulin signaling, and their protective effect against oxidative stress-induced cell toxicity in cardiomyocytes H9c2. Incubation of cells with EC and DHBA reduced glucose uptake, decreased lipid content and reinforced the insulin-signaling pathway. Interestingly, EC and DHBA increased GLUT-4, decreased cluster of differentiation 36 (CD36) and fatty acid synthase (FAS), and enhanced carnitine palmitoyl transferase 1 (CPT1) and proliferator activated receptor α (PPARα) levels. By using specific inhibitors, the participation of AKT and 5’-AMP-activated protein kinase (AMPK) on glucose uptake and lipid accumulation was shown. Likewise, EC and DHBA prevented the increased ROS generation and the activation of stress-related pathways induced by oxidative insults avoiding cell death. Taken together, EC and DHBA might exert beneficial effects in cardiac cells and prevent the oxidative stress and dysfunction during diabetes; these results show the relevance of the bioactivity of flavanol-derived colonic metabolites in cardiomyocytes., Grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cocoa-Carob Blend, alone or in combination with metformin, as a new strategy to manage the diabetic cardiomyopathy. A preclinical study in Zucker diabetic rats

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Caro-Vadillo, Alicia
  • Pérez-Jiménez, Jara
  • Ramos, Sonia
  • Martín, M. Ángeles
Trabajo presentado a las XXVI Jornadas Internacionales de Nutrición Práctica y al XV Congreso Internacional de la Sociedad Española de Dietética y Ciencias de la Alimentación (SEDCA), celebradas del 29 al 31 de marzo de 2022 en Madrid., This work was supported by the grant RTI2018-095059-B-I00 funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”. E.G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020- AI/BIO-18529)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dietary supplementation with a cocoa–carob blend modulates gut microbiota and prevents intestinal oxidative stress and barrier dysfunction in Zucker diabetic rats

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Pérez-Vizcaíno, Francisco
  • Pérez-Jiménez, Jara
  • Ramos, Sonia
  • Martín, M. Ángeles
We have recently developed a cocoa–carob blend (CCB) rich in polyphenols with antidiabetic properties. In this study, we investigated whether its benefits could be related to gut health and gut microbiota (GM) composition and the likely phenolic metabolites involved. Zucker diabetic fatty rats were fed on a standard or a CCB-rich diet for 12 weeks. Intestinal barrier structure and oxidative and inflammatory biomarkers were analyzed in colonic samples. GM composition and phenolic metabolites were evaluated from feces. The results show that CCB improved mucin and tight-junction proteins and counteracted gut oxidative stress and inflammation by regulating sirtuin-1 and nuclear factor erythroid 2-related factor 2 (Nrf2) levels. CCB also modulated the composition of the GM, showing increases in Akkermansia and Bacteroides and decreases in Ruminococcus genera. Correlation analysis strengthened the associations between these genera and improved pathological variables in diabetic animals. Moreover, 12 phenolic metabolites were identified in CCB feces, being2,3-dihydroxybenzoic and 3,4,5-trihydroxybenzoic acids significantly associated with increased levels of Akkermansia and Oscillospira genera. Our findings support the potential use of CCB to prevent intestinal damage and dysbiosis in T2D, which would help to delay the progression of this pathology., This work was supported by the grants RTI2018-095059-B-I00 and PID2019-107363RB-I00, funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”. E.G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

(-)-Epicatechin and colonic metabolite 2,3-dihydroxybenzoic acid, alone or in combination with metformin, protect cardiomyocytes from high glucose/high palmitic acid-induced damage by regulating redox status, apoptosis and autophagy

  • García-Díez, Esther
  • Pérez-Jiménez, Jara
  • Martín, M. Ángeles
  • Ramos, Sonia
(−)-Epicatechin (EC) and a main colonic phenolic acid derived from flavonoid intake, 2,3-dihydroxybenzoic acid (DHBA), display antioxidant and antidiabetic activities. Diabetic cardiomyopathy (DCM) is one of the main causes of mortality in patients with diabetes, lacking a suitable treatment. Hyperglycaemia and dyslipidaemia are mainly responsible for oxidative stress and altered apoptosis and autophagy in cardiomyocytes during DCM. In this context, phenolic compounds could be suitable candidates for alleviating DCM, but have scarcely been investigated or their use in combination with antidiabetic drugs. This study evaluates the effects of EC, DHBA and antidiabetic drug metformin (MET), alone or all combined (MIX), on redox status, autophagy and apoptosis in H9c2 cardiomyocytes challenged with high concentrations of glucose (HG) and palmitic acid (PA). Under HG + PA conditions, EC, DHBA, MET and MIX equally improved redox status, reduced apoptosis induction and ameliorated autophagy inhibition. Mechanistically, all treatments alleviated HG + PA-induced oxidative stress by reinforcing antioxidant defences (∼40% increase in glutathione, ∼30% diminution in GPx activity and ∼15% increase in SOD activity) and reducing ROS generation (∼20%), protein oxidation (∼35%) and JNK phosphorylation (∼200%). Additionally, all treatments mitigated HG + PA-induced apoptosis and activated autophagy by decreasing Bax (∼15–25%), caspase-3 (∼20–40%) and p62 (∼20–40%), and increasing Bcl-2, beclin-1 and LC3-II/LC3-I (∼40–60%, ∼15–20%, and ∼25–30%, respectively). JNK inhibition improved protective changes to redox status, apoptosis and autophagy that were observed in EC-, DHBA- and MIX-mediated protection. Despite no additive or synergistic effects being detected when phenolic compounds and MET were combined, these results provide the first evidence for the benefits of EC and DHBA, comparable to those of MET alone, to ameliorate cardiomyocyte damage, that involve an improvement in antioxidant competence, autophagy and apoptosis, these effects being mediated at least by targeting JNK., This work was supported by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”. E. G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529). Technical assistance provided by Sergio Castillo-González is gratefully acknowledged (contracted by Comunidad de Madrid, PEJ-2018-TL/SAL-10236)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synergistic effect of a flavonoid-rich cocoa–carob blend and metformin in preserving pancreatic beta cells in Zucker diabetic fatty rats

  • Gallardo-Villanueva, Paula
  • Fernández-Marcelo, Tamara
  • Villamayor, Laura
  • Valverde, Ángela M.
  • Ramos, Sonia
  • Fernández-Millán, Elisa
  • Martín, M. Ángeles
This article belongs to the Special Issue Effects of Phytochemicals on Metabolic Disorders and Human Health., The loss of functional beta-cell mass in diabetes is directly linked to the development of diabetic complications. Although dietary flavonoids have demonstrated antidiabetic properties, their potential effects on pancreatic beta-cell preservation and their synergistic benefits with antidiabetic drugs remain underexplored. We have developed a potential functional food enriched in flavonoids by combining cocoa powder and carob flour (CCB), which has shown antidiabetic effects. Here, we investigated the ability of the CCB, alone or in combination with metformin, to preserve pancreatic beta cells in an established diabetic context and their potential synergistic effect. Zucker diabetic fatty rats (ZDF) were fed a CCB-rich diet or a control diet, with or without metformin, for 12 weeks. Markers of pancreatic oxidative stress and inflammation, as well as relative beta-cell mass and beta-cell apoptosis, were analyzed. Results demonstrated that CCB feeding counteracted pancreatic oxidative stress by enhancing the antioxidant defense and reducing reactive oxygen species. Moreover, the CCB suppressed islet inflammation by preventing macrophage infiltration into islets and overproduction of pro-inflammatory cytokines, along with the inactivation of nuclear factor kappa B (NFκB). As a result, the CCB supplementation prevented beta-cell apoptosis and the loss of beta cells in ZDF diabetic animals. The observed additive effect when combining the CCB with metformin underscores its potential as an adjuvant therapy to delay the progression of type 2 diabetes., This work was supported by the grants RTI2018-095059-B-I00 and PID2020-116134RB-I00 (MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”), grant P2022/BMD-7227 (Comunidad de Madrid, Spain) and grant DEM2022/PIM01 by CIBERDEM (CB07/08/0013 and CB07/08/0033), Instituto de Salud Carlos III, MCIN., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Raw data behind tables and figures- cocoa carob blend miRNA insulin sensitivity [Dataset]

  • Villalva, Marisol
  • García-Díez, Esther
  • López de las Hazas, María-Carmen
  • Iacono, Oreste Lo
  • Vicente-Díez, Ignacio
  • García-Cabrera, Sara
  • Alonso-Bernáldez, Marta
  • Dávalos, Alberto
  • Martín, M. Ángeles
  • Ramos, Sonia
  • Pérez-Jiménez, Jara
Whole dataset corresponding to a pilot controlled, acute, randomized, cross-over nutritional clinical trial in participants with T2D. This study evaluated the effects of a cocoa-carob blend (CCB) in the regulation of postprandial alterations., This work was supported by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”. Partially funded by TED2021-130962B-C21, financed by MICIU/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/ PRTR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cocoa and carob supplementation, alone or in combination with metformin, protects against hepatorenal injury in Zucker diabetic fatty rats

  • García-Díez, Esther
  • López-Oliva, Elvira
  • Pérez-Jiménez, Jara
  • Martín, M. Ángeles
  • Ramos, Sonia
The liver and kidneys are crucial for glucose homeostasis and are seriously damaged in diabetes. Cocoa and carob possess antidiabetic activity, but their hepatorenal protective effects, especially when combined with antidiabetic drugs, are unknown. The aim of this study is to investigate the effects of a cocoa–carob-supplemented diet (CC), either alone or in combination with metformin, on liver and kidney damage in Zucker diabetic fatty (ZDF) rats, a type 2 diabetes model. Male ZDF animals received a control or CC-supplemented diet, with or without metformin, and Zucker lean rats were fed the control diet. The CC-supplemented diet improved glucose tolerance and insulin resistance and alleviated functional and structural alterations in the diabetic liver and renal cortex. The CC-supplemented diet also ameliorated oxidative stress, downregulated apoptosis, and improved insulin signalling and glucose homeostasis. The combination of CC and metformin boosted several benefits as certain parameters related to morphological and structural alterations, apoptosis, oxidative stress, glucose homeostasis, and insulin resistance, were improved in comparison to animals receiving the CC-supplemented diet or metformin alone; these include the following: apoptotic index, Bax, hepatic insulin receptor or glutathione content, among others. These results demonstrate that the CC-supplemented diet alleviates the hepatorenal damage in type 2 diabetic ZDF rats, highlighting its potential alone or as an adjuvant therapy., This research was funded by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe”. E.G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cocoa–carob blend acute intake modifies miRNAs related to insulin sensitivity in type 2 diabetic subjects: a randomised controlled nutritional trial

  • Villalva, Marisol
  • García-Díez, Esther
  • López de las Hazas, María-Carmen
  • Iacono, Oreste Lo
  • Vicente-Díez, Ignacio
  • García-Cabrera, Sara
  • Alonso-Bernáldez, Marta
  • Dávalos, Alberto
  • Martín, M. Ángeles
  • Ramos, Sonia
  • Pérez-Jiménez, Jara
Postprandial metabolic disturbances are exacerbated in type 2 diabetes (T2D). Cocoa and carob, despite showing promising effects on these alterations in preclinical studies, have not yet been jointly tested in a clinical trial. Therefore, this acute, randomised, controlled, crossover nutritional trial evaluated the postprandial effects of a cocoa-carob blend (CCB) in participants with T2D (n = 20) and overweight/obesity. The subjects followed three treatments: hypercaloric breakfast (high-sugar and high-saturated fat, 900 kcal) as the control (treatment C); the same breakfast together with 10 g of the CCB, with 5.6 g of dietary fibre and 1.6 g of total polyphenols (treatment A); and the same breakfast after consuming the CCB (10 g) the night before (treatment B). Various analyses were performed, including the determination of the clinical markers of T2D (fasting and postprandial glucose and insulin, GLP-1, and glycaemic profile), satiety evaluation, analysis of exosomal miRNA expression and ex vivo determination of inflammation modulation. No effect on glucose homeostasis (glucose, insulin, and GLP-1) was found in the study population. However, eight exosomal miRNAs were found to be significantly modified owing to CCB supplementation compared with treatment C, with three of them (miR-20A-5p, miR-23A-3p, and miR-17-5p) associated with an improvement in insulin sensitivity. Furthermore, the CCB caused a decrease in hunger feelings (0-120 min), as assessed by the visual analogue scale (VAS). Finally, treatment A caused a significant decrease in the glucose increment within 0-30 min of treatment in subjects with overweight. No significant modifications were found in the other assessed parameters. The acute intake of the CCB by subjects with T2D showed modest although significant results, which need to be validated in a long-term randomised controlled trial., This work was supported by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and “ERDF A way of making Europe”. The study was partially funded by TED2021-130962B-C21 and financed by MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR. None of the funders were involved in the assessment and interpretation of the data or in manuscript preparation. E. G.-D. was the recipient of a contract from Comunidad de Madrid (PEJ-2020-AI/BIO-18529). M. V. was the recipient of a postdoctoral contract “Margarita Salas” (Plan de Recuperación, Transformación y Resiliencia) from the Spanish Ministry of Universities and Madrid Autonomous University (CA1/RSUE/2021-00588). MCLH is a recipient of of a Ramon y Cajal Grant RYC2022-037626-I, MCIU/AEI/10.13039/501100011033 and FSE+. CIBEROBN (CB22/03/00068) and CIBERDEM (CB/07/08/0013) are initiatives of the Instituto de Salud Carlos III, Spain. Ms M. Nogués Cañadas, Mr I. Escudero Abad and Ms. M. Renard are thanked for technical assistance. Ms Macarena Paredes-López, from Siemens, provided technical support during abdominal echographia and transient elastography assessments., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Protective effects of flavonoids in diabetic cardiomyopathy: A comprehensive review on the mechanistic insights

  • Ramos, Sonia
Special Issue: Polyphenol Applications., Diabetic cardiomyopathy (DCM) is one of the leading causes of mortality among diabetic patients. Flavonoid are the most abundant group of phytochemicals in fruits and vegetables, and have received increasing interest as potential chemopreventive antidiabetic agents. Flavonoids might contribute to prevent or delay DCM by regulating the cardiac metabolism, insulin signaling, oxidative stress, apoptosis, autophagy, and inflammation. Among other effects, flavonoids have been proved to enhance glucose uptake, decrease cellular lipid accumulation, or suppress oxidative stress. However, the mechanistic basis of these effects is not fully understood, and many points remain to be clarified. This review provides insight into the molecular mechanisms of flavonoid chemopreventive activity by summarizing cell culture and animal model studies., This work was supported by the grant RTI2018-095059-B-I00, funded by MCIN/AEI/10.13039/501100011033/ and by “ERDF A way of making Europe.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Papel de los polifenoles y sus metabolitos colónicos en la diabetes tipo 2: mecanismos moleculares

  • Ramos, Sonia
Resumen del trabajo presentado a las IV Jornadas de Compuestos Bioactivos y Nutracéuticos, celebradas en Tarragona del 6 al 7 de marzo de 2025., Los polifenoles, compuestos presentes en alimentos vegetales, son ampliamente metabolizados por la microbiota intestinal, generando metabolitos fenólicos con beneficios para la salud, incluida la diabetes tipo 2 (DT2). Esta enfermedad, de alta prevalencia global, puede causar complicaciones graves como la cardiomiopatía diabética (CMD), responsable de más de la mitad de las muertes relacionadas con la DT2 y para la que no existe tratamiento adecuado. La metformina (MET) es el principal tratamiento para la DT2, y los polifenoles se han propuesto como una opción segura para aliviar la CMD. La combinación de MET y polifenoles podría ofrecer terapias más eficaces contra la CMD.El objetivo de estos estudios fue investigar los efectos y mecanismos subyacentes de los polifenoles, sus metabolitos colónicosy la MET sobre las células cardíacas en la DT2. En un modelo de cultivo celular, se demostró que (-)-epicatequina, el metabolito colónico ácido 2,3-dihidroxibenzoico, MET y sus combinaciones mejoraron el estado redox y la autofagia, y redujeron la apoptosis. En las ratas Zucker diabéticas obesas alimentadas con una dieta rica en una mezcla de cacao y algarroba, se observó mejor tolerancia a la glucosa, menor resistencia a la insulina y alivio del estrés oxidativo. Estos resultados demuestran que los polifenoles y sus metabolitos tienen efectos beneficiosos comparables a los de MET frente al daño cardíaco en la DT2, al prevenir el aumento del estrés oxidativo y regular procesos celulares clave relacionados con el estado redox, lo que resalta su potencial como candidatos para la prevención de la CMD., RTI2018-095059-B-I00, financiado por MCIN/AEI/10.13039/501100011033/ y FEDER “Una manera de hacer Europa”., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Urinary metabolomics study on the protective role of cocoa in Zucker diabetic rats via 1H-NMR-based approach

  • Fernández Millán, Elisa
  • Ramos, S
  • Álvarez-Cilleros, David
  • Samino, Sara
  • Amigó, Nuria
  • Correig, Xavier
  • Chagoyen, Mónica
  • Álvarez Escolá, Carmen
  • Martí, María Ángeles
Cocoa constitutes one of the richest sources of dietary flavonoids with demonstrated anti-diabetic potential. However, the metabolic impact of cocoa intake in a diabetic context remains unexplored. In this study, metabolomics tools have been used to investigate the potential metabolic changes induced by cocoa in type 2 diabetes (T2D). To this end, male Zucker diabetic fatty rats were fed on standard (ZDF) or 10% cocoa-rich diet (ZDF-C) from week 10 to 20 of life. Cocoa supplementation clearly decreased serum glucose levels, improved glucose metabolism and produced significant changes in the urine metabolome of ZDF animals. Fourteen differential urinary metabolites were identified, with eight of them significantly modified by cocoa. An analysis of pathways revealed that butanoate metabolism and the synthesis and degradation of branched-chain amino acids and ketone bodies are involved in the beneficial impact of cocoa on diabetes. Moreover, correlation analysis indicated major associations between some of these urine metabolites (mainly valine, leucine, and isoleucine) and body weight, glycemia, insulin sensitivity, and glycated hemoglobin levels. Overall, this untargeted metabolomics approach provides a clear metabolic fingerprint associated to chronic cocoa intake that can be used as a marker for the improvement of glucose homeostasis in a diabetic context.